A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency (ASMD)
Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
A Culturally-Tailored Mobile Health and Social Media Physical Activity Intervention for Improving Physical Activity in Hispanic or Latino/Latina Adolescent and Young Adult Childhood Cancer Survivors, Walking Juntos Study
A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
A Study to Learn More About the Health of Persons With Down Syndrome After Treatment for Acute Leukemia
With a dynamic healthcare network and prominent research institutions, Austin is a significant hub for clinical trials. Key organizations like the Dell Medical School at the University of Texas at Austin, the Texas Diabetes Institute, and the Austin Cancer Center are leading advancements in medical research. These institutions are at the forefront of clinical studies, driving innovation across various fields and contributing to groundbreaking treatments and healthcare solutions.
Why choose Austin for clinical trials?
Austin, Texas, provides distinct advantages for those participating in clinical trials. The city’s vibrant and diverse population offers a rich pool of participants, enhancing the accuracy and applicability of research findings. Austin is renowned for its innovative medical research environment, driven by leading institutions that focus on pioneering advancements and cutting-edge studies.
By joining a clinical trial in Austin, participants not only contribute to significant medical research but also benefit from a highly collaborative and supportive clinical research ecosystem. The city’s commitment to advancing healthcare through research ensures that participants are involved in meaningful studies that push the boundaries of medical science.
Common conditions studied in Austin
In Austin, clinical trials address a broad spectrum of medical conditions, reflecting the city’s commitment to advancing healthcare through innovative research and specialized facilities.
Diabetes
Austin is a leading hub for diabetes research, with institutions such as the Texas Diabetes Institute and Dell Medical School conducting extensive trials. These studies focus on developing new insulin formulations, advanced glucose monitoring technologies, and innovative treatments aimed at both Type 1 and Type 2 diabetes.
Trials often explore combination therapies that integrate lifestyle changes, diet modifications, and cutting-edge pharmaceuticals to optimize glycemic control and enhance quality of life for patients.
Cancer
The Austin Cancer Center and Dell Medical School are prominent in the field of oncology, with clinical trials investigating a range of cancers including breast, prostate, and lung cancer.
These trials are at the forefront of exploring new immunotherapies, which harness the body’s immune system to target cancer cells more effectively, and targeted therapies that focus on specific genetic mutations. Additionally, cancer clinical trials often test new combinations of chemotherapy, radiation, and emerging drug therapies to improve treatment efficacy and reduce side effects.
Neurological disorders
Neurological research in Austin is concentrated on conditions such as Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis (MS). Clinical trials frequently involve testing novel drug treatments aimed at slowing disease progression, exploring new biomarkers for early diagnosis, and utilizing advanced imaging techniques to better understand disease mechanisms.
Trials may also assess the effectiveness of non-pharmacological interventions, including cognitive therapies and rehabilitation approaches.
Cardiovascular diseases
Austin’s clinical trials in cardiovascular research target a variety of conditions including hypertension, heart failure, and coronary artery disease. Studies often focus on the development of new pharmacological treatments, innovative surgical techniques, and preventive strategies to manage risk factors.
Cardiovascular clinical trials might also explore the use of new drug classes, such as novel anticoagulants or lipid-lowering agents, as well as minimally invasive procedures like catheter-based interventions and improvements in cardiac imaging.
Autoimmune disorders
Clinical trials in Austin also address autoimmune diseases such as rheumatoid arthritis, hidradenitis suppurativa and lupus. Research here investigates new biologic therapies that specifically target immune system components involved in disease pathology, as well as other immune-modulating treatments. Trials often explore the efficacy of these new treatments in reducing inflammation, managing symptoms, and improving overall disease management.
Local regulations and guidelines
In Austin, clinical trials are governed by a comprehensive set of regulations ensuring ethical conduct and participant safety. Researchers must adhere to federal guidelines from the FDA and HHS, including compliance with Title 21 of the Code of Federal Regulations, which covers aspects like informed consent, IRB approval, and Good Clinical Practice.
Institutional Review Boards (IRBs) are responsible for reviewing and approving study protocols to ensure they meet ethical standards and protect participants. Additionally, Texas state regulations, overseen by the Texas Medical Board and Health and Human Services Commission, complement federal requirements. Trials must also comply with HIPAA to safeguard participant privacy and data.
Benefits of participating in clinical trials
Volunteering in a clinical trial provides the exclusive opportunity to access innovative treatments and therapies ahead of their general release. Participants in a clinical trial will receive specialized care from leading healthcare professionals who offer personalized attention and detailed monitoring throughout the research.
Involvement in clinical trials is essential for advancing medical science and can result in important breakthroughs in both treatment and prevention. By taking part, individuals contribute significantly to the development of new medical knowledge, helping to enhance future healthcare outcomes for others.
Interested in participating in clinical trials but worried about how long they might take? Check out our comprehensive guide for all the information you need to make an informed decision.
How to enroll in a clinical trial in Austin
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify your trial: Use our intuitive search bar or filter options to locate clinical trials specific to requirements. This first step simplifies the process of finding relevant research studies tailored to your needs.
- Select your preferred location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore study details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the health profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.